Search research articles
Contact Us
Filters
Showing results (1-10 of 36) with videos related to
Page
of 4
Sort By:
Psychopharmacology
|
January 1, 1997
Biochemical studies support the assumption that dopamine plays a minor role in the EEG effects of nicotine
B Ferger, K Kuschinsky
Synapse (New York, N.Y.)
|
February 15, 2001
Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease
N Schmidt, B Ferger
Journal of Neural Transmission (Vienna, Austria : 1996)
|
January 5, 2002
Neurochemical findings in the MPTP model of Parkinson's disease
N Schmidt, B Ferger
Brain Research
|
March 4, 2000
Comparison of the novel drug Ensaculin with MK-801 on the reduction of hydroxyl radical production in rat striatum after local application of glutamate
P Teismann, B Ferger
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
May 9, 2000
In vivo effects of the putative cognitive enhancer KA-672.HCl in comparison with 8-hydroxy-2-(di-N-propylamino) tetralin and haloperidol on dopamine, 3,4-dihydroxyphenylacetic acid, serotonin and 5-hydroxyindoleacetic acid levels in striatal and cortical brain regions
P Teismann, B Ferger
Brain Research. Brain Research Protocols
|
April 25, 2000
The salicylate hydroxylation assay to measure hydroxyl free radicals induced by local application of glutamate in vivo or induced by the Fenton reaction in vitro
P Teismann, B Ferger
Behavioural Pharmacology
|
January 1, 1995
A comparison of different sensory stimuli in producing conditioned apomorphine effects
B. Ferger, K. Kuschinsky
Neuroscience
|
January 17, 2009
Comparison of intrastriatal administration of noradrenaline and l-DOPA on dyskinetic movements: a bilateral reverse in vivo microdialysis study in 6-hydroxydopamine-lesioned rats
K Buck, B Ferger
Synapse (New York, N.Y.)
|
February 17, 2001
Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease
P Teismann, B Ferger
European Journal of Pharmacology
|
June 16, 2000
Effects of ensaculin on dopamine metabolite levels and K(+)-induced glutamate release
P Teismann, B Ferger
Page
of 4
Search research articles
Search
Showing results (1-10 of 36) with videos related to
Sort By:
Page
of 4
Psychopharmacology
|
January 1, 1997
Biochemical studies support the assumption that dopamine plays a minor role in the EEG effects of nicotine
B Ferger, K Kuschinsky
Synapse (New York, N.Y.)
|
February 15, 2001
Neuroprotective effects of (+/-)-kavain in the MPTP mouse model of Parkinson's disease
N Schmidt, B Ferger
Journal of Neural Transmission (Vienna, Austria : 1996)
|
January 5, 2002
Neurochemical findings in the MPTP model of Parkinson's disease
N Schmidt, B Ferger
Brain Research
|
March 4, 2000
Comparison of the novel drug Ensaculin with MK-801 on the reduction of hydroxyl radical production in rat striatum after local application of glutamate
P Teismann, B Ferger
Progress in Neuro-Psychopharmacology & Biological Psychiatry
|
May 9, 2000
In vivo effects of the putative cognitive enhancer KA-672.HCl in comparison with 8-hydroxy-2-(di-N-propylamino) tetralin and haloperidol on dopamine, 3,4-dihydroxyphenylacetic acid, serotonin and 5-hydroxyindoleacetic acid levels in striatal and cortical brain regions
P Teismann, B Ferger
Brain Research. Brain Research Protocols
|
April 25, 2000
The salicylate hydroxylation assay to measure hydroxyl free radicals induced by local application of glutamate in vivo or induced by the Fenton reaction in vitro
P Teismann, B Ferger
Behavioural Pharmacology
|
January 1, 1995
A comparison of different sensory stimuli in producing conditioned apomorphine effects
B. Ferger, K. Kuschinsky
Neuroscience
|
January 17, 2009
Comparison of intrastriatal administration of noradrenaline and l-DOPA on dyskinetic movements: a bilateral reverse in vivo microdialysis study in 6-hydroxydopamine-lesioned rats
K Buck, B Ferger
Synapse (New York, N.Y.)
|
February 17, 2001
Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease
P Teismann, B Ferger
European Journal of Pharmacology
|
June 16, 2000
Effects of ensaculin on dopamine metabolite levels and K(+)-induced glutamate release
P Teismann, B Ferger
Page
of 4